Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
09/1991
09/07/1991CA2037531A1 Preparation, which stimulates the immune system, can be applied parenterally and has a long shelf life, and method forproducing it
09/06/1991WO1991013883A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
09/06/1991CA2077543A1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
09/05/1991WO1991013094A1 Inhibitor of proliferation of endothelial cells
09/05/1991WO1991013082A1 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
09/05/1991WO1991013077A1 Calcium channel compositions and methods
09/05/1991WO1991013055A2 New aryl- and heteroarylethenylene derivatives and process for their preparation
09/05/1991WO1991012797A1 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
09/05/1991WO1991011435A3 New centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics
09/05/1991WO1991011201A3 Compounds
09/05/1991WO1991009593A3 5-ht3 antagonists for treatment of nausea, bradycardia of hypotension associated with myocardial instability
09/05/1991WO1991006314A3 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins
09/04/1991EP0445098A2 Deoxynojirimycin derivatives as antiviral agents
09/04/1991EP0445026A1 Aminomethylpiperidine derivatives, their process for preparation and the pharmaceutical compositions containing them
09/04/1991EP0444924A1 Fused 7-membered cyclic compound and antipsychotic preparation containing the same
09/04/1991EP0444905A1 Equine aerosol drug delivery method and apparatus
09/04/1991EP0444899A2 Catechol derivatives, their physiologically acceptable salts, esters and their use in the treatment of tissue damage induced by lipid peroxidation
09/04/1991EP0444855A1 Improvements in and relating to (S)-norfluoxetine
09/04/1991EP0444854A2 6-Substituted hexahydrobenz[cd]indoles
09/04/1991EP0444853A2 Hexahydrobenz[cd]indoles
09/04/1991EP0444852A2 Crystalline salt of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenz[cd]indole
09/04/1991EP0444844A2 New 15-dehydroxy-16-oxoprostaglandins
09/04/1991EP0444532A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
09/04/1991EP0444482A2 Oxetanones
09/04/1991EP0444157A1 Collagen-polymer conjugates
09/04/1991EP0444149A1 High molecular weight human angiogenic factors
09/04/1991EP0271542B1 An acellular red blood cell substitute
09/04/1991EP0202276B1 Composition for the treatment of psoriasis
09/03/1991WO1991012792A1 Method and product for promoting hair growth and treating skin conditions
09/03/1991US5045631 Polypeptides with cell-spreading activity
09/03/1991US5045558 Aromatase inhibitors, prevention of estrogen biosynthesis, treatment of breast cancer
09/03/1991US5045548 Quinolyl methoxy compounds and their use as antiasthmatic agents
09/03/1991US5045547 Leukotriene-inhibiting substituted (quinolin-2-yl-methoxy)phenyl-N,N'-sulphonylureas and use thereas
09/03/1991US5045545 [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity
09/03/1991US5045538 Promoting protein synthesis in skeletal muscle systems
09/03/1991US5045531 Administering amphiphilic polypeptide as wound healing agent
09/03/1991US5045530 Conprising a micelle or a vesicle of a cationic teniside based on a hydrophobic alkyl-substituted pyridinium compound and a hydrophobic drug; drug delivery; skin disorders
09/03/1991US5045323 Mineral deficiencies in bones; removing contents, centrifuging, washing, rinsing, drying, crushing, grinding, sterilizing
09/03/1991US5045320 Large multivalent immunogen
09/03/1991CA2036407A1 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method
09/03/1991CA1288547C 1-(3-mercapto-2-methylpropanoyl) prolyl amino acid derivatives and salts thereof, processes for their preparation and pharmaceutical compositions containing such compounds
09/03/1991CA1288424C Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient
08/1991
08/29/1991CA2037239A1 (s)-norfluoxetine
08/29/1991CA2037088A1 Prostaglandins for inhibiting cartilage damage
08/28/1991WO1991013062A2 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
08/28/1991EP0443957A2 New 17-spiro substituted steroid compounds, process for their preparation and intermediates of this process, their use as medicines and pharmaceutical preparations containing them
08/28/1991EP0443710A1 Benzoquinone antiallergy and antiinflammatory agents
08/28/1991EP0443404A1 Peptide fragments and analogs of thrombospondin
08/28/1991CN1013673B Indenopyrimidine derivatives
08/28/1991CA2053256A1 Substituted 1-(alkoxy-iminoalkyl)imidazole derivatives
08/28/1991CA2036978A1 Aminomethylpiperidine derivatives; process for preparing the same and pharmaceutical compositions containing them
08/27/1991WO1991013054A1 Cycloalkyl-substituted glutaramide antihypertensive agents
08/27/1991US5043431 Method and apparatus for the production of TGF-β
08/27/1991US5043354 Pharmaceutically useful 5-hydroxy-2,3-dihydro-benzofurans and 5-hydroxy-benzofurans
08/27/1991US5043341 N-(2-hydroxycyclopentyl)-1-isopropyl-6-methylergoline-8-carboxamides
08/27/1991US5043335 Enzyme inhibitors; cardiovascular and central nervous system disorders
08/27/1991US5043328 Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems
08/27/1991US5043326 Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredients
08/27/1991US5043273 Phosphorylated glycosidase inhibitor prodrugs
08/27/1991CA2073450A1 Cycloalkyl-substituted glutaramide antihypertensive agents
08/27/1991CA2036964A1 Method of antiviral enhancement
08/27/1991CA1288196C Process for production of dry bioactive recombinant growth hormones
08/27/1991CA1288107C Leukotriene antagonists
08/23/1991CA2036847A1 Steroid products containing a spiro radical in position 17; process for preparing the same and intermediates for this process; their use as t erapeutic agents and
08/23/1991CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a
08/23/1991CA2036093A1 Peptide fragments and analogs of thrombospondin
08/22/1991WO1991012239A1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1α-HYDROXYLATED DERIVATIVES
08/22/1991WO1991012235A1 Allosteric hemoglobin modifiers
08/22/1991WO1991011996A1 Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them
08/22/1991WO1991011995A1 Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
08/21/1991EP0442820A1 Benzimidazole and azabenzimidazole derivatives, thromboxane receptor antagonists, processes for their preparation, synthesis intermediates, compositions containing them
08/21/1991EP0442783A1 Elfamycin compound, process for its preparation and its use
08/21/1991EP0441939A1 Wound healing
08/21/1991EP0441889A1 Modified human growth hormone
08/20/1991US5041673 Novel tetralin derivatives
08/20/1991US5041638 Alkenoic acid derivatives
08/20/1991US5041448 (4-piperidinylmethyl and -hetero) purines
08/17/1991WO1991012254A1 Substituted urea compounds and their preparation and use
08/17/1991WO1991012017A1 Heparin neutralization with platelet factor 4
08/17/1991CA2075957A1 Heparin neutralization with platelet factor 4
08/17/1991CA2074803A1 Substituted urea compounds and their preparation and use
08/17/1991CA2035710A1 Benzimidazole aqnd azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparatin, synthesis interm ediates and pharmaceutical compositions in which they are prsent
08/16/1991WO1991012322A1 COVALENT ANGIOGENIN/RNase HYBRIDS
08/16/1991CA2073434A1 Covalent angiogenin/rnase hybrids
08/14/1991WO1991012252A1 Indole derivatives, their preparation and use
08/14/1991WO1991012002A1 Imidazole angiotensin ii antagonists incorporating a substituted benzyl element
08/14/1991WO1991012001A1 Angiotensin ii antagonists incorporating a substituted benzyl element
08/14/1991WO1991011999A1 Angiotensin ii antagonists incorporating a substituted benzyl element
08/14/1991WO1991011909A1 Triazole angiotensin ii antagonists incorporating a substituted benzyl element
08/14/1991EP0441598A2 Spiroisoindole compounds
08/14/1991EP0441349A1 Pyrroloazepine derivatives
08/14/1991EP0441218A2 Anthracycline-glycosyl prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates
08/14/1991EP0441191A2 Retroisosteric dipeptides, their preparation and use as renin inhibitors in pharmaceutical compositions
08/14/1991EP0441036A2 Quinoline derivatives, processes for their preparation, intermediates, and pharmaceutical compositions containing these derivatives
08/14/1991EP0440887A1 Improvement in the total synthesis of Erbstatin analogs
08/14/1991EP0440809A1 Methylenediphosphonic acid compound and anti-inflammatory containing the same as active ingredient
08/14/1991EP0440731A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs
08/14/1991EP0302896B1 N-(w-substituted alkyl)-n'-[(imidazole-4-yl)alkyl]guanidine
08/14/1991EP0138995B1 Regulation of enzymes which utilize tetrahydrobiopterin or tetrahydrofolate cofactors with 6, 6-disubstituted-tetrahydropteridines
08/14/1991CN1013491B Fluorinated diaminoalkyne derivs
1 ... 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 ... 1564